Alcohol is a well-established, preventable cause of cancer responsible for about 100,000 cases of cancer and 20,000 cancer deaths annually in the United States,” said Surgeon General Vivek Murthy, MD.

The US Food and Drug Administration (FDA) has accepted for priority review the new drug application (NDA) for avutometinib to be used in combination with defactinib for the treatment of adults with ...

Biased patient handoffs impede accurate transfer of clinical information among medical trainees, a study suggests.

Researchers found that, in the most recent decade evaluated, the incidence of early-onset colorectal cancer increased in 27 countries and territories.

A phase 3 trial confirms “the potent anti-leukemic effect” of consolidation with allogeneic transplant in older patients with acute myeloid leukemia, according to researchers.

This page includes links to articles highlighting the top breast cancer research published on Cancer Therapy Advisor in 2024.

Researchers found that prostate cancer patients with greater socioeconomic disadvantages were less likely to receive targeted therapy, and participation in the 340B program did not counteract that.

Researchers found an association between cardiovascular disease and more advanced stage of breast cancer at diagnosis, “independent of factors associated with delayed diagnosis and shared risk.” ...

Improving Diagnosis and Access to Care Could Prevent Deaths Equitable access to care and improvements in cancer diagnosis and primary prevention strategies could prevent more than 2 million cancer ...

The FDA has approved subcutaneous nivolumab and hyaluronidase-nvhy (Opdivo Qvantig) to treat a range of solid tumor malignancies.

The platinum chemotherapy shortage resulted in a modest absolute reduction in platinum use but no difference in mortality, data suggest.

Health care spending in the United States reached $4.9 trillion ($14,570 per person) in 2023, researchers found.